2024 Volume 61 Issue 2 Pages 176-183
Background: The current situation regarding the prevention and treatment of oral mucosal disorders in pediatric patients with cancer is unknown in Japan. Therefore, we investigated institutions participating in the Japanese Children’s Cancer Group (JCCG). Methods: Between April and July 2017, the JCCG Supportive Care Committee conducted a web questionnaire survey of 153 institutions participating in the JCCG for the prevention and treatment of oral mucosal disorders. Results: Responses were received from 110 departments in 108 institutions (71%). Approximately 72% of the departments provided oral care instructions to patients. In addition, 65% of the departments provided oral care with mouthwashes and brushing. Cryotherapy was performed in 64% of the departments, of which 84% used cryotherapy for melphalan administration. When oral mucosal damage occurred, acetaminophen, nonsteroidal anti-inflammatory drugs, and opioids were used to alleviate pain. Discussion: Oral care for children with cancer has not yet been standardized in Japan. Further research is needed to improve the oral care of pediatric patients with cancer.